JSX has begun flying the ATR 42-600, testing turboprops on premium routes as it looks to reach more small and underserved ...
Public charter carrier JSX has celebrated a key milestone in its introduction of the ATR 42-600 into the US market following ...
AstraZeneca has had a setback in its late-stage oncology pipeline, after AKT inhibitor ceralasertib, given in combination with cancer immunotherapy Imfinzi, failed to extend survival in a lung cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback